Immutep

Entity > Corporation > AU > Melbourne Victoria > Immutep

About Immutep

Industry: Business & Industrial > Pharmaceuticals & Biotech

More information about Immutep

Company Attribute Value
Address StreetAddress: 33 Australia Sq L 264, AddressLocality: Sydney, AddressRegion: New South Wales, PostalCode: 2000, AddressCountry: Australia
Founding Date 2001
Name Immutep
Number Of Employees 35
Revenue $4,252,000 USD
Ticker Symbol NASDAQ: IMMP
Url immutep
Facebook facebook
Linkedin linkedin
Twitter twitter
Wikipedia wikipedia
Google google
Wikidata wikidata

Immutep

au

Melbourne, AU
26 Mar 2024

Melbourne, AU
26 Mar 2024

Immutep

All
News
Images
Maps
Videos
More
Page: 1 Desktop | Laptop Devices

https://www.immutep.com/
Immutep | LAG-3 Immunotherapy for Cancer & Autoimmune ...
Immutep is a leading biotechnology company focused on developing effective autoimmune and cancer immunotherapy treatments such as Lag-3.
https://twitter.com/Immutep?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor
Immutep (@Immutep) · X
https://finance.yahoo.com › quote › IMMP
Immutep Limited (IMMP) Stock Price, News, Quote & History
Find the latest Immutep Limited (IMMP) stock quote, history, news and other vital information to help you with your stock trading and investing.
https://en.wikipedia.org › wiki › Immutep
Immutep
Immutep Ltd (formerly Prima Biomed) is a biotechnology company working primarily in the field of cancer immunotherapy using the LAG3 immune control ...
https://www.asx.com.au › markets › company › IMM
IMM share price and company information for ...
View today's IMM share price, options, bonds, hybrids and warrants. View announcements, advanced pricing charts, trading status, fundamentals, ...
https://www.facebook.com/Immutep/
Immutep Limited | Sydney NSW
Immutep Limited, Sydney, Australia. 767 likes · 5 talking about this · 3 were here. Immutep is the global leader in developing LAG-3 therapeutics (ASX:...
Related Searches
Related Searches
immutep news today
immutep sas
immutep buyout
Knowledge Panel
Knowledge Panel

Immutep (Biotechnology company)

immutep.com/

Immutep Ltd is a biotechnology company working primarily in the field of cancer immunotherapy using the LAG3 immune control mechanism. The company was originally built on CVac, a therapeutic cancer vaccine. In late 2014 the privately held French immunotherapy company Immutep SA was purchased by Prima Biotech.

en.wikipedia.org/wiki/Immutep
  • Stock price : IMM (ASX) $0.39 0.00 (+1.32%)26 Mar, 10:05 am AEDT - Disclaimer
  • CEO : Marc Voigt (July 2014–)
  • Headquarters : New South Wales
  • Founded : 2001

All information on this page is taken from publicly available sources, and the analysis we provide is a representation of Google's search results for the entity and does not represent any opinion or judgement about the entity by Kalicube itself. If you disagree with this analysis, please contact us and cite this reference : 193947